Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$184.7M
+55.3% from 2023
Prescriptions
5,462
$33,815.31 per claim
Patients
1,016
1,007 prescribers
Total spending, 2024
$184.7M
$181,790.60 per patient
Medicare prescription drug plans paid $184.7M for Idhifa in 2024, for 5,462 prescriptions and refills to 1,016 patients (up 55.3% from 2023). The average cost per claim was $33,815.31.
Texas had the highest Medicare cost for Idhifa in 2024: $17.5M for 528 claims, followed by New York ($16.6M).
Elizabeth D Weiland, nurse practitioner in Charleston, SC, had the highest Medicare cost for Idhifa in 2024: 43 claims costing $1.4M.
Idhifa is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as Celgene/BMS.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Elizabeth D Weiland Charleston, SC | Nurse Practitioner | 43 | Under 11 | $1.4M |
| Brian A Jonas Sacramento, CA | Hematology-Oncology | 40 | Under 11 | $1.3M |
| Yazan Madanat |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 672 | 3,031 | 677 | $93.7M |
| 2023 | 808 | 3,608 | 813 | $118.9M |
| 2024 | 1,007 | 5,462 | 1,016 | $184.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 37 |
| Under 11 |
| $1.2M |
| Shannon R McCurdy Philadelphia, PA | Hematology-Oncology | 34 | Under 11 | $1.1M |
| Justin M Watts Miami, FL | Hematology-Oncology | 30 | Under 11 | $1.1M |
| Gregory K Behbehani Columbus, OH | Hematology-Oncology | 32 | Under 11 | $1.1M |
| Matthew L Ulrickson Gilbert, AZ | Hematology-Oncology | 32 | Under 11 | $1.1M |
| Sara A Carlough Houston, TX | Physician Assistant | 29 | Under 11 | $936K |
| Alexis M Cruz-Chacon San Juan, PR | Hematology-Oncology | 27 | Under 11 | $916K |
| Mark Levis Baltimore, MD | Medical Oncology | 28 | Under 11 | $894K |
| Aileen Go Maywood, IL | Hematology-Oncology | 26 | Under 11 | $886K |
| Praneeth Baratam Charleston, SC | Hematology-Oncology | 27 | Under 11 | $880K |
| Sarah J Jimenez Augusta, GA | Nurse Practitioner | 28 | Under 11 | $874K |
| Yesid Alvarado Valero Houston, TX | Hematology | 25 | Under 11 | $863K |
| David A Sallman Tampa, FL | Internal Medicine | 25 | Under 11 | $855K |
| Karen P Seiter Hawthorne, NY | Hematology-Oncology | 24 | Under 11 | $802K |
| Neil C Dunavin Zion, IL | Hematology | 25 | Under 11 | $798K |
| Kimberly Conrad Charlottesville, VA | Nurse Practitioner | 23 | Under 11 | $793K |
| Antoine N Saliba Rochester, MN | Hematology-Oncology | 20 | Under 11 | $776K |
| Courtney D Dinardo Houston, TX | Hematology-Oncology | 23 | Under 11 | $769K |
| Rupa Narayan Boston, MA | Hematology-Oncology | 23 | Under 11 | $767K |
| Paul B Koller Duarte, CA | Hematology | 23 | Under 11 | $759K |
| Misty L Mahaffey Stanford, CA | Nurse Practitioner | 23 | Under 11 | $737K |
| Laura A Galindo Folsom, CA | Nurse Practitioner | 22 | Under 11 | $725K |
| Alec S Goldenberg New York, NY | Hematology-Oncology | 16 | Under 11 | $720K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Celgene/BMS BMY | 5,462 | $184.7M |